Pieris Pharmaceuticals Inc banner

Intrinsic Value

Not Available for PVLA

There is not enough data to reliably calculate the intrinsic value for Pieris Pharmaceuticals Inc.

Do our valuations actually work? See backtest results .

Alternatives to PVLA

Fundamental Analysis

What Pieris Pharmaceuticals Does

Biotechnology Health Care

Pieris Pharmaceuticals is a biotechnology company that develops protein-based medicines using its Anticalin platform, a way to design small, stable proteins that can bind to disease targets. The company’s main work is to create drug candidates for serious illnesses, especially in areas like cancer and respiratory disease, and then advance them through testing.

Headquarters
United States of America US
Employees
124
IPO date
Dec 18, 2014
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pieris Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

PVLA Insider Trading
Buy and sell transactions by insiders